MG
MDT icon

Michael Gelband’s Medtronic MDT Stock Holding History

Michael Gelband’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-44,754
Closed -$3.9M – 1831
2025
Q2 		$3.9M Sell
44,754
-476,538
-91% -$40.4M 0.03% 497
2025
Q1 		$46.8M Buy
521,292
+53,925
+12% +$4.83M 0.46% 29
2024
Q4 		$37.3M Sell
467,367
-441,181
-49% -$38.2M 0.26% 57
2024
Q3 		$81.8M Buy
908,548
+643,034
+242% +$54.1M 0.5% 26
2024
Q2 		$20.9M Buy
+265,514
New +$21.8M 0.14% 125
2024
Q1 		– Sell
-388,062
Closed -$32M – 1780
2023
Q4 		$32M Buy
388,062
+223,424
+136% +$17M 0.21% 64
2023
Q3 		$12.9M Buy
164,638
+118,717
+259% +$9.94M 0.12% 176
2023
Q2 		$4.05M Sell
45,921
-45,420
-50% -$3.91M 0.03% 530
2023
Q1 		$7.36M Sell
91,341
-96,729
-51% -$7.88M 0.06% 385
2022
Q4 		$14.6M Buy
188,070
+123,864
+193% +$10M 0.21% 108
2022
Q3 		$5.18M Buy
+64,206
New +$5.77M 0.07% 387
2022
Q1 		– Sell
-157,937
Closed -$16.3M – 2480
2021
Q4 		$16.3M Buy
157,937
+90,461
+134% +$10.5M 0.17% 105
2021
Q3 		$8.46M Sell
67,476
-15,576
-19% -$2.02M 0.11% 232
2021
Q2 		$10.3M Buy
83,052
+6,642
+9% +$834K 0.11% 143
2021
Q1 		$9.03M Sell
76,410
-99,341
-57% -$11.6M 0.13% 141
2020
Q4 		$20.6M Buy
175,751
+123,956
+239% +$13.6M 0.2% 48
2020
Q3 		$5.38M Sell
51,795
-11,525
-18% -$1.16M 0.11% 164
2020
Q2 		$5.81M Buy
63,320
+5,507
+10% +$528K 0.15% 125
2020
Q1 		$5.21M Buy
57,813
+24,357
+73% +$2.59M 0.29% 57
2019
Q4 		$3.8M Buy
+33,456
New +$3.67M 0.07% 205
2019
Q2 		– Sell
-8,592
Closed -$783K – 1246
2019
Q1 		$783K Buy
+8,592
New +$769K 0.06% 235

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Michael Gelband's MDT Position: Q3 2025 in Review

Michael Gelband sold out of Medtronic (MDT) in Q3 2025, closing a stake of 44,754 shares — an estimated $3.9M sold.

Michael Gelband first reported a position in MDT in Q1 2019 and held it in 21 quarters. The position peaked at $81.8M in Q3 2024. 2,174 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

  • Michael Gelband reported no remaining Medtronic position as of Q3 2025 after selling out during the quarter.
  • Michael Gelband sold 44,754 Medtronic shares in Q3 2025, an estimated $3.9M.
  • Michael Gelband first reported a position in Medtronic in Q1 2019 and held it in 21 quarters.
  • Michael Gelband's Medtronic position peaked at $81.8M in Q3 2024.
  • 2,174 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on ExodusPoint Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.